We present two cases of aspergillus infection confirmed by blood culture and review 30 other cases of genuine aspergillus fungemia and 34 cases of aspergillus pseudofungemia. Multiple different media and blood culture systems were used to isolate Aspergillus. The median time to positive blood culture was 8.5 days (range, 1-27 days) in the genuine cases. Genuine aspergillus fungemia was observed more often after cardiac surgery (n = 11 [34%]) or during neutropenia (n = 9 [28%]) than in other settings. In a recent series of fungemia during neutropenia, 7.6% of all episodes were due to Aspergillus. Other patients at risk for aspergillus fungemia were similar to those at risk for invasive aspergillosis, including patients with AIDS. Seven (44%) of 19 patients who were treated survived. In the group of patients with aspergillus pseudofungemia, there were no deaths, and cultures of additional specimens from the same patient were not positive. Criteria that may be applied to ascertain whether the isolation of Aspergillus from blood cultures is clinically significant are put forward. We present two cases of aspergillus fungemia and review 30 cases of genuine aspergillus fungemia. These cases are compared with 34 cases of contamination of blood cultures with Aspergillus species (aspergillus pseudofungemia). We present criteria for distinguishing genuine aspergillus fungemia from aspergillus pseudofungemia.
cultures of human specimens of blood. We recorded the underlying diseases, predisposing factors, organs involved, other sites positive for Aspergillus (both before and after death) in culture, blood culture methods, time to positive culture, species, treatment, and, if described, outcome. Criteria for genuine aspergillus fungemia (definite and probable) and aspergillus pseudofungemia are listed in table 1. The source of contamination for aspergillus pseudofungemia was noted.
Case Reports Case 1
A 76-year-old woman with a history of temporal arteritis managed with high doses of prednisolone presented with a history of right orbital swelling, pain in the right eye, and cough. Computerized axial tomography and magnetic resonance imaging demonstrated a right orbital mass on both sides of the lateral orbital wall that extended to and invaded the soft tissues of the right infratemporal fossa. Small additional lesions were noted in the left mastoid region on the right and in the left cerebellum. Gallium 67 scanning at 72 hours also demonstrated an abnormal accumulation in the right orbit. Biopsy of the accumulation showed only granulomatous inflammation and no hyphae. A sputum culture yielded Aspergillusfumigatus, and treatment with amphotericin B (total dose, 500 mg) was initiated. The patient was then discharged and continued therapy as an outpatient. She failed to tolerate this therapy and was readmitted for stabilization of her condition. The dose of amphotericin B was reduced from 50 mg to 35 mg daily. During this admission Staphylococcus aureus pneumonia developed. After a total dose of amphotericin B of 1,510 mg was administered, her signs and symptoms resolved, and she was discharged. She Commentary. This patient suffered an unusual form of invasive aspergillosis that has been infrequently described [8, 9] . Histologic evidence of scanty hyphae, which may not be present at all in a small biopsy sample, has been previously noted in cases of this disease entity, perhaps reflecting a vigorous local immune response. The response to amphotericin B therapy and relapse are also characteristic of this form of invasive aspergillosis. Nineteen patients were treated systemically with antifungal therapy, and seven (44%) of these patients survived. Of eight patients who did not receive treatment, all died. One patient (case 3) underwent a valve replacement only and survived [13] . Among the other 10 patients who underwent cardiovascular surgery, two were treated, but all died. Of the 12 patients with cancer and/or neutropenia, 10 were treated, and six (50%) survived. Our second patient (case 32) simply had the Mediport removed. Aspergillus was isolated in 21 (66%) of the 32 genuine cases of fungemia while the patient was alive and in eight cases (25%) after the patient died; no data were available for three cases. The median time to positive culture was 8.5 days (range, 1-27 days) in the eight genuine cases in which it was recorded. Concurrent bacteremia was uncommon but occurred in four patients with leukemia [28] . In most instances Microbiological details provided in the reports were scanty. Methods used for blood culture are outlined in table 4. In addition to these methods, we are aware of a number of instances of both true and false-positive isolation of Aspergillus related to the lysis-centrifugation system.
Discussion
Disseminated aspergillosis is an increasing problem in the severely immunocompromised patient. Aspergillus infections develop in ~5%-12% of bone marrow transplant patients [26, 33] , 13% of heart transplant recipients [34] , and 4% of patients with AIDS [35, 36] . A recent survey of cancer centers in Europe [37] showed that at least 13 cases of invasive aspergillosis occurred annually in up to one-quarter of the centers. Among the affected patients the rates of response to amphotericin B treatment varied from 6% to 87%; the overall response rate was ~55% among those who received therapy for at least 2 weeks [34] . Delayed intervention is associated with higher mortality; therefore, early recognition of the infection is important [4] . Present diagnostic modalities for aspergillus infection are inadequate. The role of blood culture has been little explored.
Although several investigators have examined the problems involved in interpreting the importance of pulmonary isolations of Aspergillus species [38] [39] [40] , the significance of isolations of Aspergillus species in blood cultures is less clearly enunciated. Aspergillus fungemia is apparently a rare infection; it represents only 0.5%-2% of all fungemias [2, 3] . However, in a recent series of cases of fungemia from a leukemia and bone marrow transplant unit [28] , 7.6% were due to A. fumigatus.
Review of the literature and comparison of the circumstances surrounding genuine aspergillemia and aspergillus pseudofungemia suggest that both clinical and laboratory criteria can be used to evaluate the likely significance of asper- NOTE. BHI = brain-heart infusion; BCB = BCB Combi Set (trypticase soy broth, Hoffmann-La Roche, Basel, Switzerland).
* Some with subculture to Sabouraud medium.
gillus fungemia (table 5) . To prove that these features are significant would require a complex case-control study with multivariate analysis, which is difficult to undertake given the rarity of the problem. Certain features deserve emphasis. [52, 53] , and use of hypertonic media (such as 10% sucrose) [54] . To our knowledge, none of these modifications have been associated with increased isolation rates of Aspergillus. Agitation of the Roche Septi-Chek system improves the isolation of yeast [53] and might be expected to speed the growth of Aspergillus. To our knowledge, Aspergillus has never been isolated on bacterial media used in the BACTEC system (Becton Dickinson, Cockeysville, MD); however, this finding could reflect the inadequate production of carbon dioxide [55] or the lack of terminal subcultures [56] . Recently, a new fungal medium for the BACTEC system has been introduced; this medium is associated with good isolation rates in the BACTEC 660 system [57] , but to our knowledge no Aspergillus species have been isolated yet.
Clusters of Aspergillus isolates in
Compared with more conventional blood culture systems, use of the lysis-centrifugation system resulted in a significant increase in the isolation of fungi in early studies [57] [58] [59] [60] . This system also allows quantitation of cfu. However, the method of processing is prone to contamination [61] , and Aspergillus is one of the potential airborne contaminants. Processing in a laminar air-flow facility should prevent airborne contamination. Aside from the problem of contamination, isolator systems cannot be automated and therefore are more labor intensive [53, 62] .
At present the diagnosis of invasive aspergillosis is based on many factors, including the patient's immune status, results of radiology, and culture and histologic data. Serology may be helpful in the diagnosis, but the sensitivity of this test is still relatively limited [63] [64] [65] . Confirmation of the diagnosis can be elusive. If aspergillus fungemia could be detected as often as it occurs clinically, as manifested by disseminated disease, then there would be clear benefits for the management of cases. Development of an optimal blood culture system may be justified for the increasing numbers of high-risk patients.
